The influence of evolutionary landscapes on protective antibody development
进化景观对保护性抗体发育的影响
基本信息
- 批准号:10531875
- 负责人:
- 金额:$ 47.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-24 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntibody AffinityAntibody ResponseAntigensBindingBiological AssayBiophysicsCommunicable DiseasesDataDengueDevelopmentDirected Molecular EvolutionEpitopesEvolutionFrustrationGenerationsGenesGerm LinesGerm-Line MutationGrowthHIVHeadHemagglutininHumanImmunoglobulin Somatic HypermutationIn VitroInfluenzaInfluenza HemagglutininLibrariesLinkMapsMeasuresMethodsMissionModernizationMotivationMutagenesisMutationNational Institute of Allergy and Infectious DiseasePathway AnalysisPatientsPerformancePlayProbabilityProcessPropertyProtein EngineeringProteinsPublic HealthReactionRefractoryResearchResearch Project GrantsResearch SupportRoleScientistScreening ResultSortingStructureStructure of germinal center of lymph nodeSurface Plasmon ResonanceTestingTherapeuticVaccine DesignVaccinesVariantViralVirusVirus DiseasesYeastsadaptive immunityanalysis pipelineanti-influenzaantibody librariesantigen bindingdeep sequencingdesignexperimental studyhuman pathogenimprovedin vivoinfluenza virus straininfluenza virus vaccineinnovationinsightinterestmembermutation screeningneutralizing antibodypandemic influenzapathogenpreventprophylacticresponsestemsuperinfectiontooluniversal influenza vaccinevaccine candidatevaccine developmentvaccine strategy
项目摘要
One of the most pressing issues in modern vaccine development is the poor heterosubtypic neutralizing
antibody responses elicited by highly diverse viruses that pose major threats to public health. Elicitation of
these so-called broadly neutralizing antibodies (bnAbs) – or antibodies that bind and neutralize many different
viral subtypes – are rare in human patients, which complicates vaccine development and allows for repeated
annual viral infections (e.g., Influenza and Dengue) or even superinfection (HIV) in human patients. In
particular, current vaccines elicit bnAbs at insufficient titers for long-lasting protection against all currently
circulating and pandemic Influenza strains. Therefore, it is critical to understand why some Abs are selected
over others (i.e., why they are immunodominant), an issue directly relevant to the design of effective vaccines
for many recalcitrant infectious diseases.
Our long-term objective is to map the development of antibody lineages in a way that enables the prediction of
likely responses as a tool to manipulate the process of antibody selection. Our primary objective is to test the
hypothesis that the antibody evolutionary landscape is more limited for anti-Influenza bnAbs than for subtype-
specific Abs, with this difference explaining why these bnAbs are not often selected at high levels in humans.
To test this hypothesis we will display Influenza-specific antibody libraries on yeast and use a transformative
sorting and deep sequencing pipeline to evaluate each member variant of the library for its affinity and
nonspecific binding properties. This massive functional data will then be used for a network analysis to
reconstruct plausible evolutionary trajectories for each somatic bnAb and subtype-specific head Ab. The
motivation for the proposed research is guided by the urgent need for develop methods to map and manipulate
rules of in vivo antibody affinity maturation to develop vaccines against refractory pathogens of high interest to
public health including Influenza, Dengue, and HIV.
The proposed research project will be carried out by pursuing three specific aims:
1) Determine ontogeny from germ line to mature human antibodies for two heterosubtypic HA stem binders;
2) Determine ontogeny from germ line to mature human antibodies for four heterosubtypic and subtype-
specific HA head binders;
3) Determine the number of evolutionary trajectories from a representative germline Ab.
This approach is innovative because it combines a unique hypothesis with state of the art protein
engineering tools needed to evaluate the hypothesis, and it is significant because the data generated here will
illuminate why long-lasting bnAb responses to HA immunogens are so rare. The approach raised in this
application may also expedite rational structure-based design of vaccines, prophylactics, and therapeutics
against a range of human pathogens.
现代疫苗开发中最紧迫的问题之一是可怜的异质型中和
高度潜水病毒引起的抗体反应对公共卫生构成了重大威胁。启发
这些所谓的广泛中和抗体(BNAB)或结合许多不同的抗体
病毒亚型 - 在人类患者中很少见,这使疫苗发育复杂化并允许重复
人类患者的年病毒感染(例如流感和登革热)甚至超级感染(HIV)。
特别的,当前的疫苗会引起bnabs的滴度不足,无法持续保护目前的所有疫苗
循环和大流行性流感菌株。因此,重要的是要了解为什么选择一些腹肌
在其他方面(即为什么它们是免疫降低的),这是与有效疫苗设计直接相关的问题
对于许多顽固的传染病。
我们的长期目标是以一种能够预测的方式来绘制抗体谱系的开发
可能的响应是操纵抗体选择过程的工具。我们的主要目标是测试
假设抗体进化景观对抗Influenza bnabs的限制更为限制
特定的ABS,有这种差异,解释了为什么这些BNAB在人类中通常不经常被高水平选择。
为了检验该假设,我们将在酵母上显示流感特定的抗体库并使用变革性
分类和深层测序管道,以评估库的每个成员变体的亲和力和
非特异性结合特性。然后,此庞大的功能数据将用于网络分析
重建每个体细胞BNAB和亚型特异性头AB的合理进化轨迹。这
拟议研究的动机是迫切需要开发绘制和操纵方法的迫切需要的
体内抗体亲和力成熟的规则,以开发针对高疗法病原体的疫苗
包括流感,登革热和艾滋病毒在内的公共卫生。
拟议的研究项目将通过追求三个具体目标来实现:
1)确定从种系到成熟的人类抗体的个体发育,用于两个异源HA茎粘合剂;
2)确定从种系到成熟的人类抗体的本体发育
特定的HA头粘合剂;
3)确定来自代表性种系AB的进化轨迹数量。
这种方法具有创新性,因为它将独特的假设与最先进的蛋白质结合在一起
评估假设所需的工程工具,这很重要,因为此处生成的数据将
阐明了为什么持久的BNAB对HA免疫原的反应如此罕见。在此提出的方法
应用还可以加快疫苗,预防和治疗的基于理性结构的设计
针对一系列人类病原体。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Method for User-defined Mutagenesis by Integrating Oligo Pool Synthesis Technology with Nicking Mutagenesis
- DOI:10.21769/bioprotoc.3697
- 发表时间:2020-08-05
- 期刊:
- 影响因子:0.8
- 作者:Steiner, Paul J.;Baumer, Zachary T.;Whitehead, Timothy A.
- 通讯作者:Whitehead, Timothy A.
Facile Assembly of Combinatorial Mutagenesis Libraries Using Nicking Mutagenesis.
- DOI:10.1007/978-1-0716-2152-3_6
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Optimization of multi-site nicking mutagenesis for generation of large, user-defined combinatorial libraries
- DOI:10.1093/protein/gzab017
- 发表时间:2021-02-15
- 期刊:
- 影响因子:2.4
- 作者:Kirby, Monica B.;Medina-Cucurella, Angelica, V;Whitehead, Timothy A.
- 通讯作者:Whitehead, Timothy A.
Standardizing cassette‐based deep mutagenesis by Golden Gate assembly
通过 Golden Gate 组装标准化基于盒的深度诱变
- DOI:10.1002/bit.28564
- 发表时间:2023
- 期刊:
- 影响因子:3.8
- 作者:Daffern, Nicolas;Francino‐Urdaniz, Irene M.;Baumer, Zachary T.;Whitehead, Timothy A.
- 通讯作者:Whitehead, Timothy A.
The importance and future of biochemical engineering
- DOI:10.1002/bit.27364
- 发表时间:2020-05-29
- 期刊:
- 影响因子:3.8
- 作者:Whitehead, Timothy A.;Banta, Scott;Wheeldon, Ian
- 通讯作者:Wheeldon, Ian
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Andrew Whitehead其他文献
Timothy Andrew Whitehead的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Andrew Whitehead', 18)}}的其他基金
The influence of evolutionary landscapes on protective antibody development
进化景观对保护性抗体发育的影响
- 批准号:
10310456 - 财政年份:2019
- 资助金额:
$ 47.05万 - 项目类别:
The influence of evolutionary landscapes on protective antibody development
进化景观对保护性抗体发育的影响
- 批准号:
10084802 - 财政年份:2019
- 资助金额:
$ 47.05万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:82273723
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
- 批准号:82204046
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 47.05万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 47.05万 - 项目类别:
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
B 细胞表位发现和抗体保护机制:对登革热 4、Powassan、基孔肯雅热和委内瑞拉马脑炎病毒的反应
- 批准号:
10909763 - 财政年份:2023
- 资助金额:
$ 47.05万 - 项目类别: